ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+7.74%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$167M
AUM Growth
+$167M
(-14%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-16.23%
Top 10 Holdings %
Top 10 Hldgs %
42.83%
Holding
127
New
32
Increased
5
Reduced
15
Closed
34
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$4.58M |
| 2 |
Penumbra
PEN
|
$4.46M |
| 3 |
Alphatec Holdings
ATEC
|
$4.21M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$3.18M |
| 5 |
Varex Imaging
VREX
|
$3M |
Top Sells
Sector Composition
| 1 | Healthcare | 91.74% |
| 2 | Financials | 3.92% |
| 3 | Technology | 0.91% |
| 4 | Communication Services | 0.54% |
| 5 | Materials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Astria Therapeutics
ATXS
$349M
| $17.9M | 9.95% | 1,347,088 -8,284 | -0.6% | -$110K |
|
2
ADMA Biologics
ADMA
$4.12B
| $9.5M | 5.27% | 2,870,000 | – | – |
|
|
BLU
3
DELISTED
BELLUS Health Inc.
BLU
| $8.15M | 4.52% | 1,132,000 | – | – |
|
|
KDNY
4
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $7.06M | 3.92% | 305,000 -80,000 | -21% | -$1.85M |
|
5
Amylyx Pharmaceuticals
AMLX
$836M
| $5.43M | 3.01% | 185,000 +45,000 | +32% | +$1.32M |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $5.41M | 3% | 620,000 -405,000 | -40% | -$3.53M |
|
7
Arcellx
ACLX
$3.85B
| $4.62M | 2.57% | 150,000 | – | – |
|
|
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.58M | 2.54% | +500,000 | New | +$4.58M |
|
9
Glaukos
GKOS
$5.5B
| $4.56M | 2.53% | 91,000 | – | – |
|
|
10
Penumbra
PEN
$10.6B
| $4.46M | 2.48% | +16,000 | New | +$4.46M |
|
|
11
Alphatec Holdings
ATEC
$2.35B
| $4.21M | 2.34% | +270,000 | New | +$4.21M |
|
12
Myriad Genetics
MYGN
$593M
| $4.18M | 2.32% | 180,000 -32,000 | -15% | -$743K |
|
13
NeoGenomics
NEO
$1.13B
| $4.18M | 2.32% | 240,000 -45,000 | -16% | -$783K |
|
|
AKYA
14
DELISTED
Akoya BioSciences
AKYA
| $4.09M | 2.27% | 500,000 +170,000 | +52% | +$1.39M |
|
15
Xtant Medical Holdings
XTNT
$83.3M
| $3.97M | 2.2% | 6,227,559 -18,732 | -0.3% | -$11.9K |
|
16
ResMed
RMD
$40.2B
| $3.72M | 2.07% | 17,000 | – | – |
|
|
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.57M | 1.98% | 850,000 +400,000 | +89% | +$1.68M |
|
18
Biohaven
BHVN
$1.63B
| $3.55M | 1.97% | 260,000 +60,000 | +30% | +$820K |
|
|
RETA
19
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.18M | 1.77% | +35,000 | New | +$3.18M |
|
|
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.16M | 1.76% | 130,000 -60,000 | -32% | -$1.46M |
|
|
21
Varex Imaging
VREX
$480M
| $3M | 1.67% | +165,000 | New | +$3M |
|
22
Inspire Medical Systems
INSP
$2.77B
| $2.93M | 1.62% | +12,500 | New | +$2.93M |
|
23
KORU Medical Systems
KRMD
$195M
| $2.89M | 1.6% | 685,002 -169,998 | -20% | -$717K |
|
24
Replimune Group
REPL
$422M
| $2.61M | 1.45% | 148,000 -12,000 | -8% | -$212K |
|
25
BridgeBio Pharma
BBIO
$9.89B
| $2.57M | 1.43% | +155,000 | New | +$2.57M |
|